Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect
Open accessThe DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The regulation of HSC proliferation and engraftment of the BM is an important but poorly understood process, particularly during ontogeny. Here we show that in mice, all HSCs are cycling until 3 weeks after birth. Then, within 1 week, most became quiescent. Prior to 4 weeks of age, the proliferating HSCs with long-term multilineage repopulating activity displayed an engraftment defect when transiting S/G2/M. During these cell cycle phases, their expression of CXC chemokine ligand 12 (CXCL12; also referred to as stromal cell-derived factor 1 [SDF-1]) transiently increased. The defective engrafting activity of HSCs in S/G2/M was reversed when cells were allowed to progress into G1 prior to injection or when the hosts (but not the cells) were pretreated with a CXCL12 antagonist. Interestingly, the enhancing effect of CXCL12 antagonist pretreatment was exclusive to transplants of long-term multilineage repopulating HSCs in S/G2/M. These results demonstrate what we believe to be a new HSC regulatory checkpoint during development. They also suggest an ability of HSCs to express CXCL12 in a fashion that changes with cell cycle progression and is associated with a defective engraftment that can be overcome by in vivo administration of a CXCL12 antagonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“HSCs isolated from the fetal liver (FL-HSCs) at embryonic day 14.5 (E14.5), a developmental time at which HSCs are known to be highly cycling (Bowie et al., 2006; Morrison et al., 1995; Nygren et al., 2006; Pietras et al., 2011)”
From Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle (2014) · cites this paper as Bowie et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“mined as previously described (76), and the housekeeping Gapdh gene tran-”
MethodMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140 · cited 8×
“Gene expression analysis of the G 1 and S/G 2 /M subsets of highly purified lin – Sca1 + CD43 + Mac1 + HSCs from 14.5-dpc FL and 3-wk BM. Gene expression in G 1 was set as 1, and the fold change in transcript levels in the corresponding S/G 2 /M fraction is shown.”
BackgroundInfluentialBmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
Park, I.-K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., & Clarke, M. F. (2003) · Nature · doi:10.1038/nature01587 · Cited by 1,871 · cited 1×
“These include genes encoding various transcription factors, i.e., Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
BackgroundDependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644 · cited 1×
“…be predicted from the explanation we have advanced, forced overexpression of CXCR4 in retrovirally transduced (i.e., proliferating) human HSCs was able to enhance the in vivo engrafting activity of these cells (68), and, conversely, treatment with antibodies to CXCR4 had the opposite effect (69).”
BackgroundBmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
Lessard, J., & Sauvageau, G. (2003) · Nature · doi:10.1038/nature01572 · Cited by 1,452 · cited 1×
“, Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana-Seisdedos, F., Fujii, N., et al. (2002) · Nature Immunology · doi:10.1038/ni813 · Cited by 1,332 · cited 1×
“However, CXCL12 levels in the BM are also subject to regulation, as occurs, for example, following the administration of G-CSF (70).”
BackgroundDenhardt, D. T., Noda, M., O’Regan, A. W., Pavlin, D., & Berman, J. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12980 · Cited by 1,059
How do stem cells find their way home?
Lapidot, T., Dar, A., & Kollet, O. (2005) · Blood · doi:10.1182/blood-2005-04-1417 · Cited by 985 · cited 1×
“Previous work has suggested that the ability of transplanted HSCs to reach a niche within the BM that can support their self maintenance may depend on the strength of the CXCL12 gradient they encounter within the BM space, causing them to migrate toward the osteoblasts that line the bone (22).”
BackgroundBroxmeyer, H. E., Orschell, C. M., Clapp, D. W., Hangoc, G., Cooper, S., Plett, P. A., Liles, W. C., Li, X., Graham-Evans, B., Campbell, T. B., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041385 · Cited by 970 · cited 1×
“To date, interference of CXCL12 action by specific CXCR4 inhibitors has been used primarily for enhancing the yield of HSCs from donors for transplantation into myeloablated patients (71, 72).”
Cited by
Items 201–300 of 379
Wang, H., Zhang, Z., Han, C., Jiang, P., Xu, J., Han, Y., Huang, D., Li, J., Zhou, J. R., Durnin, M., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-024-01593-7 · Cited by 19
“In contrast, most HSCs entered quiescence within 1 week postnatally, whereas those in the S/G2/M phase were engraftment defective 67,68 .”
Agrawal, H., Mehatre, S. H., & Khurana, S. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104585 · Cited by 23
Ghosh, J., & Kapur, R. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0067-z · Cited by 16
“The PDH complex have three catalytic subunits, pyruvate dehydrogenase (E1), dihydrolipoamide transacetylase (E2), and dihydrolipoamide dehydrogenase (E3) [74]. PDH kinases (Pdks) phosphorylate PDHs and inhibit their activity. Pdks are highly expressed in murine LTHSCs and PDH-E1 is highly phosphorylated in LT-HSCs com…”
BackgroundInfluentialDevelopment of the hematopoietic system: Role of inflammatory factors
Hayashi, Y., Sezaki, M., & Takizawa, H. (2019) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.341 · Cited by 19
“HSCs actively cycle for the first 3 weeks and thereafter, establish and maintain quiescence and lifelong blood production (Bowie et al., 2006).”
BackgroundErythropoietin Markedly Attenuates Brain Infarct Size and Improves Neurological Function in the Rat
Yuen, C.-M., Leu, S., Lee, F.-Y., Yen, C.-H., Lin, Y., Chua, S. O., Chung, S., Chai, H., Sheu, J., Ko, S., et al. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181e80c40 · Cited by 15
Nakano, M., Nishimura, M., Hamasaki, K., Mishima, S., Yoshida, M. A., Nakata, A., Shimada, Y., Noda, A., Nakamura, N., & Kodama, Y. (2014) · Radiation Research · doi:10.1667/rr13446.1 · Cited by 15
Bernitz, J. M., Rapp, K., Daniel, M. G., Shcherbinin, D., Yuan, Y., Gomes, A., Waghray, A., Brosh, R., Lachmann, A., Ma’ayan, A., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.005 · Cited by 17
“This switch corresponds to a shift from proliferation to quiescence (Bowie et al., 2006),”
BackgroundMenendez-Gonzalez, J. B., & Hoggatt, J. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10272-1 · Cited by 15
“In addition, virtually all of the fetal liver HSCs are actively cycling, while almost all adult bone marrow HSCs are quiescent [114].”
BackgroundSpecification of hematopoietic stem cells in mammalian embryos: A rare or frequent event?
Ganuza, M., Clements, W. K., & McKinney‐Freeman, S. (2021) · Blood · doi:10.1182/blood.2020009839 · Cited by 16
Fetal to Adult Stem Cell Transition: Knocking Sox17 off
Jang, Y.-Y., & Sharkis, S. J. (2007) · Cell · doi:10.1016/j.cell.2007.07.027 · Cited by 13
“At 4 weeks after birth, HSCs shift from a proliferating fetal phenotype to a quiescent adult phenotype (Bowie et al., 2006).”
BackgroundMiller, P. H., Knapp, D. J. H. F., Beer, P. A., MacAldaz, M. E., Rabu, G. M., Cheung, A. M. S., Wei, L. L., & Eaves, C. J. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.04.003 · Cited by 15
Self-citationTarnawsky, S. P., Chan, R. J., & Yöder, M. C. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94031 · Cited by 16
“Flt3Cre has an expression pattern markedly different from that of Mx1Cre, which may explain the observed respective myeloid versus lymphoid disease outcomes.”
BackgroundInfluentialBone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential
Kohutek, Z. A., Caslin, H. L., Fehrenbach, D. J., Heimlich, J. B., Brown, J. D., Madhur, M. S., Ferrell, P. B., & Doran, A. C. (2025) · Circulation Research · doi:10.1161/circresaha.124.323778 · Cited by 21
Bonora, M., Kahsay, A., & Pinton, P. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.05.003 · Cited by 18
Zhang, Y., Clay, D., Mitjavila‐Garcia, M. T., Alama, A., Mennesson, B., Berseneff, H., Louache, F., Griscelli, A. B., & Oberlin, E. (2018) · Stem Cells and Development · doi:10.1089/scd.2018.0154 · Cited by 14
Bai, L., Xu, Y., Qian, S., Xiang, Z., Xuan, S., & Wu, J. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1186850 · Cited by 16
“For example, in the bone marrow, HSCs proliferate the first 3 weeks after birth and after that they stay in quiescence for a long time (Bowie et al., 2006).”
BackgroundUse of Imaging Techniques to Illuminate Dynamics of Hematopoietic Stem Cells and Their Niches
Morikawa, T., & Takubo, K. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00062 · Cited by 12
“Another study reports active division of murine HSCs in bone marrow until 3 weeks of age, but after 4 weeks HSCs stop dividing and become quiescent (Bowie et al., 2006).”
BackgroundAskenasy, N. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.09.002 · Cited by 12
“Cycling fetal hematopoietic progenitors are stabilized in a state of mitotic quiescence within the bone marrow in the early post-natal period [1].”
BackgroundFetal hematopoietic stem cells are making waves
Waas, B., & Maillard, I. P. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.03.06 · Cited by 12
“Fetal HSCs are thought to seed the more quiescent adult HSC compartment that will sustain the adult hematopoietic system, a process taking place in the bone marrow after it becomes available to support hematopoiesis (5-7).”
BackgroundRunx Family Genes in Tissue Stem Cell Dynamics
Wang, C. Q., Mok, M. M. H., Yokomizo, T., Tergaonkar, V., & Osato, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_9 · Cited by 12
Huang, L., Li, F., Ye, L., Yu, F., & Wang, C. (2023) · Cell Proliferation · doi:10.1111/cpr.13413 · Cited by 11
IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development
Thambyrajah, R., Maqueda, M., Fadlullah, M. Z. H., Proffitt, M., Neo, W. H., Guillén, Y., Casado-Peláez, M., Molinero, P. H., Brujas, C., Castelluccio, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48854-5 · Cited by 16
Jimenez, D. V., Adusumilli, V. S., Stempel, M. H., Maday, S., Ming, G., Song, H., & Bond, A. M. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114339 · Cited by 13
Chan, D. C. H., Xu, J., Vujovic, A., Wong, N., Gordon, V. D., de Rooij, L. P. M. H., Moreira, S., Joyce, C. E., Rose, J. L., Sandí, M. J., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002539 · Cited by 12
Otsuka, K., Nielson, C., Firpo, M. A., Park, A. H., & Beaudin, A. E. (2021) · Cells · doi:10.3390/cells10123596 · Cited by 11
“The fetal HSC compartment contains more lymphoid-biased progenitors [58], are less quiescent [59,60], express different phenotypic markers suggestive of functional differences [61,62], and produce distinct mature cell output.”
BackgroundKrenn, P. W., Montañez, E., Costell, M., & Fässler, R. (2022) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2022.02.009 · Cited by 11
Csf1rb regulates definitive hematopoiesis in zebrafish
Dai, Y., Wu, S., Cao, C., Xue, R., Luo, X., Wen, Z., & Xu, J. (2022) · Development · doi:10.1242/dev.200534 · Cited by 11
Transcriptional reprogramming in neonatal hematopoietic stem and progenitor cells
Li, Y., & Magee, J. A. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.07.004 · Cited by 14
Infant leukaemia – faithful models, cell of origin and the niche
Duguid, A., Mattiucci, D., & Ottersbach, K. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049189 · Cited by 13
“From E11 onwards, there is rapid HSC expansion, with highly proliferative HSCs found in this new niche (Bowie et al., 2006).”
BackgroundH2S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets
Liu, H., Zhang, A., Xu, J., Chen, Y., & Zhu, Y. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0244-7 · Cited by 12
“In the embryonic period, hematopoiesis mainly occurs in the liver where the hematopoietic stem cells were differentiated into various types of blood cells [50–52].”
BackgroundHasemann, M. S., Damgaard, I., Schuster, M. B., Theilgaard‐Mönch, K., Sørensen, A. B., Mršić, A., Krugers, T., Ylstra, B., Pedersen, F. S., Nerlov, C., et al. (2008) · Blood · doi:10.1182/blood-2007-06-097790 · Cited by 11
New insights into the endothelial origin of hematopoietic system inspired by “TIF” approaches
Hou, S., Guo, X., Du, J., Ding, X., Ning, X., Wang, H., Chen, H., Liu, B., & Lan, Y. (2024) · Blood Science · doi:10.1097/bs9.0000000000000199 · Cited by 12
The evolving hematopoietic niche during development
Sánchez‐Lanzas, R., Jiménez‐Pompa, A., & Ganuza, M. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1488199 · Cited by 12
Cacialli, P., Dogan, S., Linnerz, T., Pasche, C., & Bertrand, J. Y. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.05.022 · Cited by 10
“Remarkably, murine adult bonemarrowHSCs rapidly switch to a quiescent state by 4 weeks of age, as only 5% of total HSCs are actively engaged in the cell cycle (Bowie et al., 2006).”
SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26
Hildebrandt, M. (2007) · Frontiers in bioscience · doi:10.2741/2798 · Cited by 10
“Interestingly, SDF-1 (5-68) has been shown to possess neurotoxicity which leads to neuronal apoptosis in murine basal ganglia and may contribute to neurodegenerative processes observed in HIV-infected individuals (47).”
BackgroundReturn to youth with Sox17: Figure 1.
Chhabra, A., & Mikkola, H. K. A. (2011) · Genes & Development · doi:10.1101/gad.17328611 · Cited by 9
“In contrast, fetal HSCs can also engraft, even though they are in cell cycle (Passegue et al. 2005; Bowie et al. 2006).”
BackgroundInfluentialFine-tuning of hematopoietic stem cell homeostasis: novel role for ubiquitin ligase
Yokomizo, T., & Dzierzak, E. A. (2008) · Genes & Development · doi:10.1101/gad.1669908 · Cited by 11
“HSCs change from a rapidly proliferating state to a quiescent state between 3 and 4 wk after birth (Bowie et al. 2006).”
BackgroundGarcia-Gimenez, A., & Richardson, S. E. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1150612 · Cited by 9
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase C
Binder, V., Li, W., Faisal, M. S., Oyman, K., Calkins, D. L., Shaffer, J. L., Teets, E. M., Sher, S., Magnotte, A., Belardo, A. M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112528 · Cited by 12
“HSPCs cycle rapidly in the CHT 19,20 and its murine cognate, the fetal liver, 69–71 in part to meet the needs of the developing organism.”
Schuermans, A., Nakao, T., Ruan, Y., Koyama, S., Yu, Z., Uddin, M. M., Haidermota, S., Hornsby, W., Lewandowski, A. J., Bick, A. G., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030220 · Cited by 11
Rozenova, K., Jiang, J., Donaghy, R., Aressy, B., Greenberg, R. A., & Tong, W. (2015) · Blood · doi:10.1182/blood-2014-07-588145 · Cited by 9
Defining the Emerging Blood System During Development at Single-Cell Resolution
Karlsson, G., Sommarin, M. N. E., & Böiers, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660350 · Cited by 12
“Fetal and adult HSCs differ molecularly, in lineage potentials, as well as in cell cycle activity (Ema and Nakauchi, 2000; Bowie et al., 2006; Kim et al., 2007; Yuan et al., 2012; Beaudin et al., 2016; Popescu et al., 2019).”
BackgroundDissecting infant leukemia developmental origins with a hemogenic gastruloid model
Ragusa, D., Suen, C.-W. W., Torregrosa-Cortés, G., Pastorino, F., Johns, A., Cicirò, Y., Dijkhuis, L., van den Brink, S., Cilli, M., Byrne, C., et al. (2025) · eLife · doi:10.7554/elife.102324.3 · Cited by 10
Population mixture model for nonlinear telomere dynamics
Itzkovitz, S., Shlush, L. I., Glück, D., & Skorecki, K. L. (2008) · Physical Review E · doi:10.1103/physreve.78.060902 · Cited by 10
Hamasaki, K., Landes, R. D., Noda, A., Nakamura, N., & Kodama, Y. (2016) · Radiation Research · doi:10.1667/rr14385.1 · Cited by 9
“In contrast, the hematolymphoid system is exceptional because the majority of HSCs do not locate into their bone marrow niches prior to birth, but only at 3–4 weeks after birth (26).”
Wei, H., Liu, Y., Huang, C., Wang, C., Jiang, H., Wang, L., Wang, Y., & Wang, Z. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119917 · Cited by 8
Aberrant stem cell and developmental programs in pediatric leukemia
Ling, R. E., Cross, J. W., & Roy, A. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1372899 · Cited by 12
In vivo divisional tracking of hematopoietic stem cells
Takizawa, H., & Manz, M. G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06500.x · Cited by 10
Expansion of Quiescent Hematopoietic Stem Cells under Stress and Nonstress Conditions in Mice
Zhang, S., Ma, Y., Wang, L., Li, X., Dong, Y., Wang, J., Cheng, T., Dong, F., & Ema, H. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10380-6 · Cited by 10
“Most HSCs are cycling and expand in the postnatal BM for 4 weeks [40, 41] and remain at the G0 phase thereafter [40].”
BackgroundLux, C. T., & Yöder, M. C. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103118cl · Cited by 10
“…studies have indicated a significant change in the cycling behavior of HSC over the first two weeks of life as HSC activity becomes predominant in the bone marrow microenvironment rather than the neonatal liver (Bowie et al., 2007; Bowie et al., 2006; Dykstra et al., 2007; Sieburg et al., 2006).”
Marginal expression of CXCR4 on c-kit+Sca-1+Lineage− hematopoietic stem/progenitor cells
Sasaki, Y., Matsuoka, Y., Hase, M., Toyohara, T., Murakami, M., Takahashi, M., Nakatsuka, R., Uemura, Y., & Sonoda, Y. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0451-x · Cited by 9
“Whereas the mRNA expression of CXCR4 has been reported to be detectable in murine CD34KSL cells [10] and LinSca-1CD43Mac1 cells [32] by QRT-PCR, the surface expression of the receptor has not yet been investigated.”
BackgroundAn, N., Janech, M. G., Bland, A. M., Lazarchick, J. J., Arthur, J. M., & Kang, Y. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.08.004 · Cited by 8
“The SDF1/CXCR4 interaction is important in attracting HSCs into the niches, anchoring HSCs in the niches, and maintaining HSCs in a quiescent state [17–20].”
BackgroundTrafficking of Murine Hematopoietic Stem and Progenitor Cells in Health and Vascular Disease
SCHULZ, C., von Andrian, U. H., & Maßberg, S. (2009) · Microcirculation · doi:10.1080/10739680902948351 · Cited by 9
“In newborn mice, all HSPCs are rapidly proliferating until three weeks after birth [10].”
BackgroundFaltusová, K., Chen, C., Heizer, T., Báječný, M., Szikszai, K., Páral, P., Savvulidi, F. G., Renešová, N., & Nečas, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00098 · Cited by 9
Ontogeny of the Hematopoietic System
Ciau‐Uitz, A., Patient, R. K., & Medvinsky, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.01002-x · Cited by 13
Regulation of HSC development and function by Lin28b
Cox, G., Kobayashi, M., Rudd, B. D., & Yoshimoto, M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1555877 · Cited by 10
Tremblay, C. S., Saw, J., Yan, F., Boyle, J. A., Amarasinghe, O., Abdollahi, S., Vo, A. N. Q., Shields, B. J., Mayoh, C., McCalmont, H., et al. (2025) · Leukemia · doi:10.1038/s41375-024-02491-5 · Cited by 9
Yim, Y. S., Noh, Y.-J., Kim, D.-H., Lee, M. W., Cheuh, H. W., Lee, S. H., Yoo, K. H., Jung, H. L., Sung, K. W., Choi, S. J., et al. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.05.146 · Cited by 7
Loss of Atg2b and Gskip Impairs the Maintenance of the Hematopoietic Stem Cell Pool Size
Sakai, S., Hasegawa, A., Ishimura, R., Tamura, N., Kageyama, S., Komatsu‐Hirota, S., Abe, M., Ling, Y., Okuda, S., Funayama, M., et al. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00024-21 · Cited by 10
“This might be due to the differences between fetal and adult HSCs—selfrenewal and proliferation are accelerated in fetal HSCs to produce abundant hematopoietic progeny in the developing embryos, while adult HSCs are largely quiescent and only occasionally enter the cell cycle to maintain hematopoietic homeostasis (33,…”
BackgroundBarone, C., Orsenigo, R., Cazzola, A., D’Errico, E., Patelli, A., Quattrini, G., Vergani, B., Bombelli, S., Marco, S. D., D’Orlando, C., et al. (2023) · Cancers · doi:10.3390/cancers15143624 · Cited by 8
“Recent work shows that the pool of HSCs fated to adult life undergoes limited cell divisions during gestation [23]; thus, in this scenario, the previously observed extensive proliferation of FL HSPCs would primarily be carried out by a pool of stem/progenitor cells ultimately fated to differentiation [21,23,43].”
BackgroundBuckley, S., & Verfaillie, C. M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3147-2.00004-3 · Cited by 12
Zhu, H. H., & Feng, G. (2011) · Cell Cycle · doi:10.4161/cc.10.14.15861 · Cited by 7
He, W., Qiu, H., Feng, Y., Qiu, Q., Zheng, L., Pan, C., Cui, X. J., Sun, Y., Wang, B., & Hu, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08050-9 · Cited by 7
Modeling of human T cell developmentin vitroas a read-out for hematopoietic stem cell multipotency
Strubbe, S., & Taghon, T. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210144 · Cited by 7
Watt, S. M., & Roubelakis, M. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020671 · Cited by 7
Embryonic Development of Hematopoietic Stem Cells: Implications for Clinical Use
Clapes, T., & Robin, C. (2012) · Regenerative Medicine · doi:10.2217/rme.11.120 · Cited by 7
Aging, Somatic Evolution, and Cancer
Rozhok, A. I., & DeGregori, J. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-420190-3.00012-0 · Cited by 7
Mendoza‐Castrejon, J., & Magee, J. A. (2023) · Immunological Reviews · doi:10.1111/imr.13180 · Cited by 9
Dissecting dormancy and quiescence in hematopoietic stem cells
Ibneeva, L., & Grinenko, T. (2024) · Frontiers in Hematology · doi:10.3389/frhem.2024.1401713 · Cited by 8
Nakano, M., Kodama, Y., Ohtaki, K., & Nakamura, N. (2012) · Radiation Research · doi:10.1667/rr3074.1 · Cited by 6
“It is well known that hematopoitic stem cells move during fetal life and most enter the bone marrow niche several weeks after birth in mice (16).”
BackgroundGarcia-Ortega, A. M., Cañete, A., Quinter, C., Silberstein, L., Piquer‐Gil, M., Álvarez‐Dolado, M., Dekel, B., Göttgens, B., & Sánchez, M. J. (2009) · Stem Cells · doi:10.1002/stem.228 · Cited by 8
Wang, Q., Han, Y., Li, L., & Qian, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00042-3 · Cited by 7
Haematopoietic development and HSC formation in vitro: promise and limitations of gastruloid models
Dijkhuis, L., Johns, A., Ragusa, D., van den Brink, S., & Pina, C. (2023) · Emerging Topics in Life Sciences · doi:10.1042/etls20230091 · Cited by 7
Bone marrow imaging reveals the migration dynamics of neonatal hematopoietic stem cells
Takihara, Y., Higaki, T., Yokomizo, T., Umemoto, T., Ariyoshi, K., Hashimoto, M., Sezaki, M., Takizawa, H., Inoue, T., Suda, T., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03733-x · Cited by 5
Moore, M. A. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-227-8_30 · Cited by 5
Experimental Limitations Using Reprogrammed Cells for Hematopoietic Differentiation
Seiler, K., Tsuneto, M., & Melchers, F. (2011) · BioMed Research International · doi:10.1155/2011/895086 · Cited by 6
Hematopoietic Stem Cells Characteristics: From Isolation to Transplantation
Fathi, E., Ehsani, A., Sanaat, Z., Vandghanooni, S., Farahzadi, R., & Montazersaheb, S. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220211160954 · Cited by 6
Controlling stem cell fate one substrate at a time
Garrison, B. S., & Rossi, D. J. (2010) · Nature Immunology · doi:10.1038/ni0310-193 · Cited by 5
Berent-Maoz, B., Montecino‐Rodriguez, E., Fice, M. P., Casero, D., Seet, C. S., Crooks, G. M., Lowry, W. E., & Dorshkind, K. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125414 · Cited by 5
“This change inHmga2 expression results in a reduction of HSC self-renewal and regenerative potential [4, 5], which in turn contributes to the switch from highly active fetal to steady-state adult hematopoiesis that occurs in mice by six weeks after birth [6–8].”
BackgroundRegulation of Hematopoietic Stem Cells
Rörby, E. (2014) · Lund University Publications (Lund University) · Cited by 6
Decoding the development of the blood and immune systems during human fetal liver haematopoiesisPreprint
Popescu, D.-M., Botting, R. A., Stephenson, E., Green, K., Jardine, L., Calderbank, E. F., Efremova, M., Acres, M. J., Maunder, D., Végh, P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/654210 · Cited by 5
Integrative Single-cell RNA-Seq and ATAC-Seq Analysis of Human Developmental HaematopoiesisPreprint
Ranzoni, A. M., Tangherloni, A., Berest, I., Riva, S. G., Myers, B., Strzelecka, P. M., Xu, J., Panada, E., Mohorianu, I. I., Zaugg, J. B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.06.080259 · Cited by 8
“This is remarkably different from previous studies in mice, where an extensive proliferation of HSPCs in the bone marrow continued up to three weeks after birth (Bowie et al., 2006).”
Sox17 and Other SoxF-Family Proteins Play Key Roles in the Hematopoiesis of Mouse Embryos
Nobuhisa, I., Melig, G., & Taga, T. (2024) · Cells · doi:10.3390/cells13221840 · Cited by 4
Formation of an adherent hematopoietic expansion culture using fucoidan
Irhimeh, M. R., Fitton, J. H., Ko, K., Lowenthal, R. M., & Nordon, R. E. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1185-4 · Cited by 4
Stem Cells, Hypoxia and Hypoxia-Inducible Factors
Watt, S. M., Tsaknakis, G., Forde, S. P., & Carpenter, L. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-227-8_18 · Cited by 4
Chromatin factor YY1 controls fetal hematopoietic stem cell migration and engraftment in mice
Saka, S., Lu, Z., Wang, Y., Liu, P., Singh, D. K., Lee, J. P., Palii, C. G., Alvarez, T. R., Assumpção, A. L. F. V., You, X., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188140 · Cited by 5
“Although FL HSCs undergo a developmental transition to adult BM HSCs around 3–4 weeks after birth (28), their physiological and functional characteristics remain distinct (29–32).”
Ishida, T., Mercoli, J. I., Heck, A. M., Phelps, I. G., Varnum‐Finney, B., Dozono, S., Nourigat-Mckay, C., Kraskouskas, K., Wellington, R., Waltner, O. G., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116289 · Cited by 4
Bone marrow and the hematopoietic stem cell niche
Calvi, L. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00003-8 · Cited by 4
Hematopoietic Stem Cell Development in Mammalian Embryos
Hou, S., Liu, C., Yao, Y., Bai, Z., Gong, Y., Wang, C., He, J., You, G., Zhang, G., Liu, B., et al. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-7471-9_1 · Cited by 5
Effect of Radiation Exposures on Fetal Hematopoietic Cells
Hamasaki, K., & Nakamura, N. (2019) · Current Stem Cell Reports · doi:10.1007/s40778-019-00159-w · Cited by 3
Alonso-Ferrero, M. E., Valeri, A., Yañez, R., Navarro, S., Garin, M. I., Ramírez, J. C., Bueren, J. A., & Segovia, J. C. (2010) · Gene Therapy · doi:10.1038/gt.2010.160 · Cited by 4
Koh, C. P., Bahirvani, A. G., Wang, C. Q., Yokomizo, T., Ng, C. E. L., Du, L., Tergaonkar, V., Voon, D. C., Kitamura, H., Hosoi, H., et al. (2022) · Gene · doi:10.1016/j.gene.2022.147049 · Cited by 3
Tacke, M., Ball, C. R., Schmidt, M., Klingenberg, S., Maurer, B., Fessler, S., Eaves, C. J., Kalle, C. V., & Glimm, H. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0202 · Cited by 3
Self-citationHematopoietic Stem Cells in Transit— Where's the Niche?
Magnusson, M., & Mikkola, H. K. A. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.03.017 · Cited by 3
“This relationship between HSC cycling and function is developmentally timed and shifts to the adult phenotype 3–4 weeks after birth in mice (Bowie et al., 2006).”
BackgroundBattle in stem cell niches: Canonical versus noncanonical Wnt signaling
Chen, S., & Liu, Y. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2ce1117-453rr · Cited by 3
Smith, S. C., & Zhang, L. (2025) · Genes · doi:10.3390/genes16070798 · Cited by 2
Three-dimensional genome reorganization in hematopoietic stem cells
Nakajima, A., Kirito, K., Nakanishi, M., & Takayama, N. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.105249 · Cited by 2
Ganuza, M., & Yoshimoto, M. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.105352 · Cited by 4
Return to the hematopoietic stem cell origin
Samokhvalov, I. M. (2012) · Cell Regeneration · doi:10.1186/2045-9769-1-9 · Cited by 3
“Fetal HSCs are known to actively proliferate [1] and normally stem cell proliferation is accompanied by their differentiation into committed hematopoietic progenitors.”
BackgroundBone Marrow Hematopoietic Niches
Wu, J. Y., & Kronenberg, H. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00007-4 · Cited by 2
Metadata
- Authors
- Bowie, M. B., McKnight, K. D., Kent, D. G., McCaffrey, L., Hoodless, P. A., & Eaves, C. J.
- Affiliations
- BC Cancer Agency (CA)
- Corresponding author
- Eaves, C. J.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-10-02
- Volume
- 116
- Issue
- 10
- Pages
- 2808-2816
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1578623
- OpenAlex
- W2052350491
- Cited by
- 380
- References
- 79
- Citations by year
- 2026: 7 · 2025: 22 · 2024: 16 · 2023: 22 · 2022: 18 · 2021: 26 · 2020: 20 · 2019: 9 · 2018: 17 · 2017: 17 · 2016: 24 · 2015: 18 · 2014: 24 · 2013: 15 · 2012: 18
- FWCI
- 13.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stem Cell Network
- Michael Smith Health Research BC
- Terry Fox Foundation
- National Institutes of Health
- Canadian Institutes of Health Research
- National Heart, Lung, and Blood Institute (P01HL055435, P01 HL 55435)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- hematopoietic stem cells, HSC proliferation, HSC quiescence, cell cycle, S/G2/M phase, CXCL12, hematopoietic ontogeny, bone marrow transplantation
- MeSH terms
- Animals, Animals, Newborn, Bone Marrow Cells, Cell Cycle, Fluorouracil, Graft Survival, Hematopoiesis, Hematopoietic Stem Cells, Hematopoietic System, Liver, Mice, Inbred C57BL, Thymidine, Gene Expression, Hematopoietic Stem Cell Transplantation, Hyaluronan Receptors, Proto-Oncogene Proteins c-kit, Vascular Cell Adhesion Molecule-1, Receptors, CXCR4, Chemokines, CXC, Integrin alpha4, Cell Proliferation, Mice, Chemokine CXCL12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.